New York Times columnist and former Nixon speechwriter William Safire is the latest prominent conservative to endorse embryonic stem cell research. Yesterday, Safire devoted his column to his hope that former president Ronald Reagan’s long battle with Alzheimer’s may help to break the impasse blocking greater federal support of research into the cells and their potential to help millions of American’s including those with Alzheimer’s.
Safire cogently argues that
this research, whether the government likes it or not, is growing apace. Unless we act now to direct it toward morally acceptable ends–cure and treatment of disease and the extension of active life, not monstrous manipulation and production of clones for spare parts–we risk losing the imperfectability that makes us human.
This is the point that many opponents of stem cell research miss: that by not funding embryonic stem cell research, which will continue regardless, the federal government misses its chance to effectively shape and regulate the direction that research takes.
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.